Redmile Group, LLC Lava Therapeutics Nv Transaction History
Redmile Group, LLC
- $1.28 Billion
- Q4 2024
A detailed history of Redmile Group, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Redmile Group, LLC holds 2,074,372 shares of LVTX stock, worth $1.93 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,074,372
Previous 2,074,372
-0.0%
Holding current value
$1.93 Million
Previous $3.44 Million
40.98%
% of portfolio
0.16%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding LVTX
# of Institutions
23Shares Held
3.36MCall Options Held
100Put Options Held
200-
Bruce & Co., Inc. Chicago, IL772KShares$717,8420.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3126KShares$117,4850.03% of portfolio
-
Pathway Financial Advisors LLC103KShares$95,3250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$60,4500.0% of portfolio
-
Two Sigma Investments, LP New York, NY48.8KShares$45,3570.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $24M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...